Health
Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants – News-Medical.Net
A recent study by researchers from Canada aimed to examine the ability of commercial assays to detect vaccine-induced antibodies and recognize the vaccination response….
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) high throughput serology assays have so far been used mainly to conduct seroprevalence studies in large cohorts to help public health decision making.
All recent seroprevalence studies only examined the detection of antibodies from natural SARS-CoV-2 infection. While most of the vaccine candidates produced detectable antibody levels in serological research assays in early phase trials, it is not clear how existing…
-
General19 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business23 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025